Monday, May 06, 2024
Smart Meter has unveiled an upgraded version of its renowned iGlucose glucose meter, now branded as iGlucose Plus.
Revamped model incorporates cutting-edge features set to revolutionize the remote blood glucose monitoring market, offering enhanced accessibility to millions of individuals managing diabetes.
The iGlucose Plus is an innovative glucose meter renowned for its user-friendly design, eliminating the need for syncing, pairing, smartphones, or Wi-Fi. Leveraging built-in cellular technology, it seamlessly transmits blood glucose results to healthcare providers in real-time, facilitating remote monitoring from any location.
With the introduction of iGlucose Plus, patients can now receive crucial notifications and reminders directly on the device, including automated alerts and proactive messages from healthcare providers or suppliers.
These notifications encompass dietary reminders aimed at promoting healthier food choices and reminders for prescription pickups from pharmacies. Featuring a vivid color LED screen, the device offers improved visibility of testing instructions and results, enhancing patient satisfaction and adherence to testing protocols. Moreover, the inclusion of Spanish language prompts caters to underserved patient demographics, ensuring broader access to care.
The iGlucose Plus boasts over-the-air software updates via cellular connectivity, enabling the seamless integration of new features at the patient level. Smart Meter's commitment to research and development is evident in this latest iteration, with enhancements such as extended battery life, strengthened cellular connectivity, and remote programming capabilities.
Combined with the company's proprietary AI-driven glucose test strip auto-replenishment service, iGlucose Plus delivers exceptional value to both customers and patients.
Given that approximately 5 million individuals with diabetes reside in rural areas, the ability to track blood glucose levels remotely is paramount. By leveraging cellular networks for immediate result transmission, iGlucose Plus ensures timely attention for these patients, minimizing the need for frequent office visits. A Howard University study revealed promising outcomes, with 70% of high-risk participants experiencing a notable reduction in A1c levels within 90 days of using iGlucose®.
Source: businesswire.com
